Diagnostics

Peer-Reviewed Study Validates Reliability and Reproducibility of Esopredict, Previse’s Prognostic Assay for Patients with Barrett’s Esophagus

BALTIMORE, Sept. 11, 2024 /PRNewswire/ -- Previse, a gastrointestinal health company, announced the publication of a study in Diagnostics highlighting the…

4 months ago

Applied DNA Launches Mpox Clade I and Clade II Testing Service

STONY BROOK, NY / ACCESSWIRE / September 11, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in…

4 months ago

Nona Scientific Welcomes Industry Veteran Robb Chapin as Chairman of Newly Launched Advisory Board

Chapin will work closely with CEO Mac McKellar to oversee the company's strategic initiatives, bringing his extensive experience in senior…

4 months ago

Genetic Technologies Invited to Join Prestigious “CancerIQ” Online Platform – Provides Access to 45 Healthcare Systems and 250 Clinics

MELBOURNE, Australia, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader…

4 months ago

Allarity Therapeutics Takes Decisive Step Toward Regaining Nasdaq Compliance with Nasdaq Listing Rule 5550(a)(2)

Boston (September 11, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to…

4 months ago

Brian Napora of Gestalt Elected as Co-Chair for DICOM Working Group 26

Newly Elected are Brian Napora (Gestalt) and Dr. Mustafa Yousif (University of Michigan) SPOKANE, Wash., Sept. 10, 2024 /PRNewswire/ -- We…

4 months ago

TURQUOISE HEALTH AND POLICY REPORTER BY MERCALIS ANNOUNCE STRATEGIC DATA PARTNERSHIP

Combination of best-in-class US payer price transparency and policy coverage data provides unrivaled visibility across the healthcare coverage and payment…

4 months ago

Healthy.io, Geisinger and Boehringer Ingelheim Reveal Milestone Data at AHA 2024

The collaboration's research demonstrates how smartphone technology achieved a 2.5x increase in testing rates, offering a promising solution for early…

4 months ago

GenomOncology Partners with Precipio to Advance Myeloid Testing and Reporting

CLEVELAND, Sept. 10, 2024 /PRNewswire/ -- September 4th, 2024.  GenomOncology, a leading provider of precision medicine software, and Precipio, a…

4 months ago

American Burn Association Study Highlights Inequities in Access to Specialized Burn Care

Spectral AI’s DeepView® System Designed to Provide Equity in Burn Care Access While Optimizing Healthcare ResourcesDALLAS, Sept. 10, 2024 (GLOBE…

4 months ago